Merck & Co. Inc. (MRK)

$ 141.42
   
  • Change Today:
    $1.88
  • 52 Week High: $156.45
  • 52 Week Low: $82.49
  • Currency: US Dollars
  • Shares Issued: 2,474.63m
  • Volume: 5,152,299
  • Market Cap: $349,962m
  • RiskGrade: 92

Latest ShareCast News

Moderna, MSD hail positive trial results for melanoma vaccine

By Michele Maatouk

Date: Friday 21 Aug 2026

(Sharecast News) - Pharmaceutlcal firms Moderna and MSD (Merck Sharp & Dohme (UK) Limited) said on on Wednesday that a personalised mRNA melanoma vaccine they are jointly developing had shown positive results in a first-ever late-stage trial.

Merck News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 141.42
Change Today $ 1.88
% Change 1.35 %
52 Week High $156.45
52 Week Low $82.49
Volume 5,152,299
Shares Issued 2,474.63m
Market Cap $349,962m
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 12
Neutral 6
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Oct-2026

Time Volume / Share Price
15:22 100 @ $141.42
15:22 110 @ $141.42
15:22 100 @ $141.42
15:22 100 @ $141.43
15:22 162 @ $141.44

Top of Page